A detailed history of D1 Capital Partners L.P. transactions in Pfizer Inc stock. As of the latest transaction made, D1 Capital Partners L.P. holds 7,621,000 shares of PFE stock, worth $200 Million. This represents 4.69% of its overall portfolio holdings.

Number of Shares
7,621,000
Previous 7,830,000 2.67%
Holding current value
$200 Million
Previous $217 Million 1.86%
% of portfolio
4.69%
Previous 4.14%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $5.28 Million - $6.19 Million
-209,000 Reduced 2.67%
7,621,000 $213 Million
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $203 Million - $233 Million
7,830,000 New
7,830,000 $217 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track D1 Capital Partners L.P. Portfolio

Follow D1 Capital Partners L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D1 Capital Partners L.P., based on Form 13F filings with the SEC.

News

Stay updated on D1 Capital Partners L.P. with notifications on news.